Surgical Innovations Group (LSE:SUN) Total Liabilities : £3.84 Mil (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Total Liabilities?

Surgical Innovations Group's Total Liabilities for the quarter that ended in Dec. 2023 was £3.84 Mil.

Surgical Innovations Group's quarterly Total Liabilities increased from Dec. 2022 (£4.63 Mil) to Jun. 2023 (£4.72 Mil) but then declined from Jun. 2023 (£4.72 Mil) to Dec. 2023 (£3.84 Mil).

Surgical Innovations Group's annual Total Liabilities declined from Dec. 2021 (£5.05 Mil) to Dec. 2022 (£4.63 Mil) and declined from Dec. 2022 (£4.63 Mil) to Dec. 2023 (£3.84 Mil).

Surgical Innovations Group Total Liabilities Historical Data

The historical data trend for Surgical Innovations Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Total Liabilities Chart

Surgical Innovations Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

4.12

5.25

5.05

4.63

3.84

Surgical Innovations Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															5.05	5.14	4.63	4.72	3.84

Surgical Innovations Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Surgical Innovations Group's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.62	+	(1.051	+	0.165
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.84

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	14.32	-	10.484
	=	3.84

Surgical Innovations Group's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.62	+	(1.051	+	0.165
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.84

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	14.32	-	10.484
	=	3.84

Surgical Innovations Group Total Liabilities Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgical Innovations Group (LSE:SUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ

Website

https://www.sigroupplc.com

Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.